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Materials and methods

Results
Clinical responses (ablation obtained) were 82% in all cases, sustained at 8 weeks of the procedure. We obtained 10 complete responses (25%) at the end of the combined treatment, 9 from stage III patients and 2 from stage IV. Major complications included severe pancreatitis with GI bleeding (1), skin burning grade III that required plastic surgery (2). No deaths were registered. Median Survival was 13 month (6 mo -2.7 year).
Conclusion
HIFU plus SC is a potentially effective and safe modality for the treatment of unresectable pancreatic cancer. 
